Format

Send to:

Choose Destination
See comment in PubMed Commons below
Fam Cancer. 2013 Jun;12(2):207-16. doi: 10.1007/s10689-013-9614-2.

Genetic modifiers of cancer risk in Lynch syndrome: a review.

Author information

  • 1School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia.

Abstract

The report by Aldred Scott Warthin in 1913 of a cancer family history and expanded on by Henry T. Lynch demonstrated one of the most enduring traits observed in patients with Lynch syndrome. The recognition of a variety of malignancies occurring at differing ages within a single family suggested the role of genetic variance on disease expression in an autosomal dominantly inherited genetic condition. With the identification of the genetic basis of Lynch syndrome and the subsequent collection of families and their medical records it has become possible to identify subtle genetic effects that influence the age at which disease onset occurs in this cancer predisposition. Knowledge about genetic modifiers influencing disease expression has the potential to be used to personalise prophylactic screening measures to maximise the benefits for family members and their carers.

PMID:
23471748
[PubMed - indexed for MEDLINE]
PMCID:
PMC3717148
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk